3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a 'Buy'
Collecting sperm from Covid-19 patients
Amount of COVID viral RNA detected at hospital admission predicts how patients will fare
Healthcare And Biotech Outlook –Final Quarter of 2020
Tube-dwelling anemone toxins have pharmacological potential, mapping study shows
These 3 Penny Stocks Could Rack up Triple-Digit Gains, Says Leerink
University of Illinois Urbana-Champaign develops autonomous robot to kill COVID-19
Sanofi, GSK to supply vaccine doses to WHO-backed alliance
More testing means more iceberg
Scientists discover new organic compounds that could have helped form the first cells
The COVID "Casedemic" & Biden's "Dark Winter" Plan
US Hospitalizations Soar Almost 40% In One Week; Wisconsin Sees New COVID-19 Record: Live Updates
BioSig abandons COVID-19 drug trial on safety concerns
Can scientists take the STING out of common respiratory viruses?
Roche wades deeper into Covid-19 fight, inking antiviral pact with $350M cash following Regeneron deal
Roche to co-develop remdesivir rival in partnership with Atea
Hidden states of the COVID-19 spike protein
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
CBD helps reduce lung damage from COVID by increasing levels of protective peptide
The Year Of Disguises
Sanofi preps trials of second COVID-19 shot, as Russia approves another
DNA-peptide interactions create complex behaviours which may have helped shape biology
News briefing: Regeneron/Sanofi post positive PhIII Dupixent data in pediatric asthma; Vineti scores $33M Series C extension
New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing
PerkinElmer Raises 3Q Sales Outlook Fueled By COVID-19 Testing Demand
White House Doctor Says Trump Tested Negative For Covid, "Is Not Infectious To Others"
3 COVID-19 Antibody Stocks That Are Leading the Race
Goldman Sachs: 2 Strong Value Stocks to Buy Now
BioNTech, Rentschler Partner For Covid-19 Vaccine Manufacturing
COVID-19 Is 'Unrestricted Bioweapon': Whistleblower Releases Second Paper Alleging 'Large-Scale, Organized Scientific Fraud'